Prognostic Significance ofASXL1Mutations in Patients With Myelodysplastic Syndromes
- 20 June 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (18), 2499-2506
- https://doi.org/10.1200/jco.2010.33.4938
Abstract
Purpose To study the incidence and prognostic impact of mutations in Additional sex comb-like 1 (ASXL1) in a large cohort of patients with myelodysplastic syndrome (MDS). Patients, Materials, and Methods Overall, 193 patients with MDS and 65 healthy volunteers were examined for ASXL1 mutations by direct sequencing and for expression levels of ASXL1. The prognostic impact of ASXL1 mutation and expression levels was evaluated in the context of other clinical and molecular prognostic markers. Results Mutations in ASXL1 occurred with a frequency of 20.7% in MDS (n = 40 of 193) with 70% (n = 28) of mutations being frameshift mutations and 30% (n = 12) being heterozygous point mutations leading to translational changes. ASXL1 mutations were correlated with an intermediate-risk karyotype (P = .002) but not with other clinical parameters. The presence of ASXL1 mutations was associated with a shorter overall survival for frameshift and point mutations combined (hazard ratio [HR], 1.744; 95% CI, 1.08 to 2.82; P = ....Keywords
This publication has 35 references indexed in Scilit:
- A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.Leukemia, 2010
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2010
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromesNature Genetics, 2010
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersNature Genetics, 2010
- IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisHaematologica, 2010
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2009
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- Myelodysplastic syndromes: biology and treatmentJournal of Internal Medicine, 2009
- The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia.Haematologica, 2007